|
End-of-day quote
Shanghai S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 10.61 CNY | -1.21% |
|
-6.11% | -9.32% |
| Market Cap | 4.24B 637M 571M 525M 476M 889M 60.49B 906M 6.26B 2.51B 31.82B 2.39B 2.34B 100B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 4.59B 689M 617M 568M 515M 962M 65.47B 980M 6.77B 2.72B 34.44B 2.59B 2.53B 109B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.59% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -1.21% | ||
| 1 week | -6.11% | ||
| 1 month | -19.50% | ||
| 3 months | +3.21% | ||
| 6 months | -5.69% | ||
| Current year | -9.32% |
| 1 week | 10.49 |  | 11.47 |
| 1 month | 10.49 | | 13.4 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 26/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 31/08/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 31/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 28/02/2018 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 28/02/2018 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 27/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/09/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 02/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 05/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -6.11% | -12.24% | -42.31% | 637M | |
| +3.19% | +11.31% | +64.28% | +155.66% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +83.74% | 658B | |
| +1.41% | +3.24% | +35.25% | +106.98% | 521B | |
| +0.42% | +3.20% | +55.81% | +69.71% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.38% | 369B | |
| +1.12% | +4.52% | +34.76% | +57.00% | 307B | |
| +6.96% | +8.86% | +11.95% | +35.06% | 290B | |
| +1.15% | +6.09% | +56.15% | +78.66% | 252B | |
| +3.06% | +9.38% | +42.48% | +112.84% | 212B | |
| Average | +1.76% | +4.74% | +40.70% | +70.27% | 426.26B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.50% | +99.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 322M 289M 265M 240M 450M 30.59B 458M 3.17B 1.27B 16.09B 1.21B 1.18B 50.75B | 1.7B 256M 229M 211M 191M 357M 24.29B 364M 2.51B 1.01B 12.78B 960M 940M 40.3B |
| Net income | 274M 41.17M 36.87M 33.92M 30.73M 57.45M 3.91B 58.52M 404M 162M 2.06B 155M 151M 6.49B | 46.25M 6.95M 6.22M 5.73M 5.19M 9.7M 660M 9.88M 68.27M 27.41M 347M 26.08M 25.53M 1.09B |
| Net Debt | 108M 16.18M 14.49M 13.33M 12.07M 22.57M 1.54B 22.99M 159M 63.79M 808M 60.71M 59.42M 2.55B | 349M 52.39M 46.92M 43.16M 39.11M 73.1M 4.97B 74.47M 515M 207M 2.62B 197M 192M 8.25B |
Employees
1,887
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CN¥10.61 | -1.21% | 10,760,189 |
| 29/10/26 | CN¥10.74 | -4.96% | 11,213,600 |
| 28/10/26 | CN¥11.30 | +4.15% | 13,666,950 |
| 27/10/26 | CN¥10.85 | -3.56% | 9,436,850 |
| 26/10/26 | CN¥11.25 | -0.44% | 8,307,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
